Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SAS Traffic figures – July 2023

2.4 million passengers traveled with SAS during July2.4 million passengers traveled with SAS in July, the highest monthly passenger figure since before the pandemic. The number of passengers increased with 82 percent compared to the same month last year, which was negatively impacted by the pilot strike. SAS’ capacity increased by 84 percent and RPK by 92 percent, compared to the same month last year. The flown load factor was 86 percent during the month. “The summer season continued with another busy month for SAS. 2.4 million passengers traveled with SAS in July, the highest passenger

Biosergen Announces Abstract Accepted for Presentation at the 11th Congress on Trends in Medical Mycology (TIMM-11)

Stockholm, Sweden – August 7, 2023 – Biosergen AB (“Biosergen” or the “Company”), a clinical stage biotech company specializing in the development of innovative anti-fungal therapies, today announced the acceptance of an abstract for oral presentation by the Company’s Chief Operating Officer Tine Kold Olesen, PhD, MBA, at the 11th Congress on Trends in Medical Mycology (TIMM-11) to take place in Athens, Greece, from October 20-23, 2023.This abstract will feature the clinical data obtained from the recently completed Phase 1 clinical trial evaluating the safety, tolerability, and

XMReality signs new deal with Guernsey Holdings LLC

XMReality Inc., the U.S. subsidiary of XMReality AB (publ), has signed a new client deal with Guernsey Holdings LLC, a top 100 restaurant franchisee in the United States and one of the largest operators of Sonic restaurants in the country.The deal will see XMReality, Inc. provide Guernsey Holdings with its Remote Guidance™ software. The software will be used to facilitate remote collaboration between colleagues and suppliers at restaurant locations owned by Guernsey Holdings.  “We are excited to welcome Guernsey Holdings to the XMReality family,” said Ryne Simeone, Vice President of

CEO Letter #3 - Train Manager Status

Dear Trophy Games Investors, I am writing to you today to provide a status update on our newest game release, Train Manager . Since its release in mid-June, the game's launch has succeeded, with over 350,000 downloads and a July revenue of 460,000 DKK, making it our most successful release to date, and it is a testament to our developer and marketing teams' hard work and dedication. The success of Train Manager is a significant milestone for Trophy Games, as it brings us closer to our ambition of

MyFirstApp; Preliminary Revenue for July 2023

Stockholm, 2023-08-07MyFirstApp Sweden AB has obtained preliminary sales figures for the month of July. The group's sales amounted to approximately 135 TSEK (43 TSEK July 2022), an increase of 214%.This decrease in sales compared to the previous months can mainly be explained by seasonal variations that are typical for the education industry. With schools closed and learning not as prominent during the summer months, we often see a temporary decline in sales. We expect sales to recover as schools reopen and learning becomes a priority again.

XNK Therapeutics to present two abstracts at the Society for Immunotherapy of Cancer’s meeting in San Diego in November

XNK Therapeutics AB today announced that the abstracts Harnessing the potential of autologous NK cells for immunotherapy of patients with advanced bladder cancer and Feeder-Free Expansion of Autologous Cytotoxic NK Cells for Acute Myeloid Leukemia Treatment will be presented at the 38[th] Meeting of the Society for Immunotherapy of Cancer (SITC) in San Diego in November.XNK Therapeutics will participate at the SITC meeting in San Diego in November and present the latest research from the company’s leading preclinical projects in bladder cancer and acute myeloid leukemia (AML). Two abstracts

AcouSort invited to give a lecture at the Acoustofluidics conference

AcouSort’s Senior Scientist Mikael Evander has been asked to give an invited lecture at Acoustofluidics 2023, which celebrates its 20th anniversary this year. Acoustofluidics is a conference dedicated to exploring the science, the engineering, and the use of micro and nanoscale acoustofluidics. The first conference was held in 2003 as part of a UK based network called USWnet. Today, the conference has grown into an international event gathering researchers working with all different aspects of acoustofluidics and its applications within life sciences.The opportunity to give an invited

EQT Private Equity to sell Schülke, a sustainability leader in infection prevention and treatment for the healthcare industry

· EQT Private Equity to sell Schülke to the ATHOS Consortium, having acquired the Company in a carve-out from Air Liquide in July 2020. The Company has delivered double digit annual revenue growth and almost doubled EBITDA in its core healthcare business over this time  · Under EQT Private Equity’s ownership, Schülke has been repositioned to focus entirely on the healthcare and life science market, while expanding into new geographies and sales channels through five add-on acquisitions   · The Company has also established itself as a sustainability leader, for example by launching a

Repurchase of Truecaller B shares in week 31, 2023

During 31 July 2023 and 4 August 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 525,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 7 June 2023. The share buyback programme will run between 7 June up until the 2024 AGM which will be held in May 2024, and is carried out in accordance “Emittentregelverket”.   On the Annual General Meeting 2023 the Board was authorized to buy back B-shares up until the

Medivir partners with world-leading liver cancer experts in new Scientific Advisory Council

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today the formation of a Scientific Advisory Council as the company intensifies its plans for next phase of development. In February, Medivir announced positive, preliminary results from the dose escalation cohorts of its candidate drug fostrox, in combination with Lenvima® and initiated the phase 2a expansion cohort. Fostrox, designed to selectively treat liver cancers while minimizing systemic side

Notice of Annual General Meeting in Sectra AB (publ)

The shareholders of the medical imaging IT and cyber security company Sectra AB  (publ) are hereby invited to the Annual General Meeting of Shareholders held on Thursday, September 7, 2023 at 16.00 (CEST) at Collegium, Teknikringen 7 in Linköping, Sweden.Shareholders who attend the AGM are invited to visit Sectra’s office at Teknikringen 20 in Linköping after the AGM, where the company will treat visitors with a light meal and show its products designed for a healthier and safer society. Registration and notification A shareholder wishing to attend the

H1/2023: EBITDA 12.6 % and ARR +10.0 % – solid foundation for growth

LeadDesk Ltd Unofficial Translation of Company Release 7/8/2023 at 9.15 am. In case the document differs from the original, the Finnish version prevails.LeadDesk Ltd Half Year Financial Report 1/1-30/6/2023 Figures in parentheses refer to the equivalent period in the previous year unless otherwise stated.  (Unaudited) January–July 2023 · Revenue EUR 14,474 (13,674) thousand, growth 5.2% · Annual recurring revenue contract base EUR 25,553 (23,228) thousand, growth 10.0% · EBITDA EUR 1,818 (1,384) thousand, 12.6 (9.8)% of revenue · EBIT EUR -705 (-1,041) thousand, -4.9 (-7.

Repurchases of shares by EQT AB during week 31, 2023

Between 31 July 2023 and 4 August 2023 EQT AB (LEI code 213800U7P9GOIRKCTB34) (“EQT”) has repurchased in total 364,176 own ordinary shares (ISIN: SE0012853455) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 1,800,000 own ordinary shares for a total maximum amount of SEK 500,000,000 that EQT announced on 14 July 2023. The repurchase program, which runs between 17 July 2023 and 25 August 2023, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation

Per Widerström to leave Catena Media's board of directors

Catena Media non-executive director Per Widerström is to step down from the board of directors after taking up a new role as CEO of 888 Holdings. Widerström, who was elected to the board in May 2019, leaves Catena Media’s board with immediate effect. Göran Blomberg, Chairman of the Board of Directors, said: “Per's extensive experience and in-depth industry knowledge have greatly benefited the board's work and the strategic direction of Catena Media. On behalf of all stakeholders, we express gratitude for his contributions and wish him every success in his new role.” The board of

Jasmine Jussila appointed Solwers new Head of Communications

Solwers Plc, Company release August 7, 2023 at 9.00 EEST Jasmine Jussila appointed Solwers new Head of Communications Jasmine Jussila (M.Sc.) has been appointed Head of Communications for the Solwers Group as of 7.9.2023. In her position, she will be responsible for the Group Communications, brand and their development and will report to Stefan Nyström, CEO. In the position, she will succeed Taina Erkkilä, who has moved to new challenges outside the company. "We would like to thank Taina, who has actively developed Solwers' communication and sustainability topics and played a key

Oneflow’s monthly ARR update: July 2023

Press release7 August 2023 Oneflow publishes its preliminary monthly ARR. Oneflow had a total ARR (Annual Recurring Revenue) of MSEK 111.8 by the end of July 2023. This is a preliminary number. All financial reports and presentations are available for download on our website here: https://oneflow.com/ir/investors/financial-reports/ For further information, please contact: Anders Hamnes, CEO and FounderMobile: +46 76 788 50 76Email: anders.hamnes@oneflow.com About Oneflow Oneflow develops, sells, and implements digital contract management and automation systems.

Clas Ohlson’s sales in July increased compared to the previous year

Sales in July increased by 11 per cent to 775 MSEK (699). Organic sales increased by 10 per cent compared to the previous year. Sales in comparable units and local currency increased by 11 per cent compared to the previous year. Online sales increased by 8 per cent to 68 MSEK (63). Compared to the same month last year the store network decreased by 4 stores. At the end of the period, the total number of stores was 221 (225).Distribution of sales Month Accumulated July Change May-July ChangeMSEK 2023/24 SEK

Desert Control AS – Share capital increase registered

ISSUER DESERT CONTROL AS Sandnes, Norway, 7 August 2023: Reference is made to the stock exchange releaseby Desert Control AS ("Desert Control" or the "Company") published on 1 August2023. The issuance of 1 million new shares has been registered with theNorwegian Register of Business Enterprises. After the transaction, DesertControl's share capital is NOK 126,980.367 divided into 42,326,789 shares, eachshare having a par value of NOK 0.003 and carrying one vote in the Company'sgeneral meeting.For further inquiries, please contact:Ole Kristian SivertsenPresident and

Eastnine enters into agreement to sell its investment in MFG

Eastnine AB (publ) (Eastnine) has entered into an agreement to sell its entire investment in the Russian fashion retailer Melon Fashion Group (MFG). The purchase price for Eastnine’s shares is approximately RUB 15.6 billion corresponding to approximately EUR 149 million based on an exchange rate of 105 EUR/RUB. The transaction is expected to be completed within two weeks. The completion of the transaction is subject to significant uncertainties and risks.As previously announced, Eastnine has intended to divest its entire investment (approximately 36 percent) in the Russian fashion retailer

Nordea Bank Abp: Repurchase of own shares on 04.08.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares04.08.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 04.08.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |41,234 |10.17 |419,213.71

Pricer sets the terms of the fully guaranteed rights issue of approximately SEK 257 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD REQUIRE ADDITIONAL PROSPECTUS, REGISTRATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE IS UNLAWFUL OR CANNOT BE MADE WITHOUT THE APPLICATION OF AN EXEMPTION FROM SUCH ACTION. REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF THIS

MOBERG PHARMA ANNOUNCES THE FINAL TERMS OF THE RIGHTS ISSUE

STOCKHOLM, 4 August 2023. On 28 June 2023, the Board of Directors of Moberg Pharma AB (publ) (OMX: MOB) (“Moberg Pharma” or the “Company”) announced that the Board of Directors had resolved to, subject to the approval of the Extraordinary General Meeting to be held on 8 August 2023 (the “EGM”), carry out a rights issue of ordinary shares and warrants (“Units”) with preferential rights for existing shareholders in the amount of approximately MSEK 100 before transaction costs (the “Rights Issue”). The Board of Directors of Moberg Pharma today announces the final terms of the Rights Issue.

DNB Bank ASA – status of share buy-back programme after week 31 2023

On 17 July 2023, DNB Bank ASA (“DNB”) announced that the company has decided to initiate a share buy-back programme comprising up to 1.5 percent of the company’s own shares, which represents a total of 23,139,197 shares.  Up to 15,271,870 shares will be bought back on trading venues by 18 October 2023, and a proposal will be made at the Annual General Meeting in 2024 to cancel the shares. At the same meeting it will also be proposed to redeem the remaining shares – up to 7,867,327 shares – from the Norwegian Government, represented by the Ministry of Trade, Industry and Fisheries (“NFD”),

There are no items matching the current filter
There are no more items matching the current filter
Back to top